Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment.
- Published In:
- Diabetology & metabolic syndrome, 17(1), 286 (2025)
- Authors:
- Liu, Renjiao, Hou, Dangmin, Leng, Mingxin, Li, Zhouhuiling, Zhang, Yifang, Liu, Lingling, Wang, Xincheng, Li, Chunjun
- Database ID:
- RPEP-12234
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12234APA
Liu, Renjiao; Hou, Dangmin; Leng, Mingxin; Li, Zhouhuiling; Zhang, Yifang; Liu, Lingling; Wang, Xincheng; Li, Chunjun. (2025). Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment.. Diabetology & metabolic syndrome, 17(1), 286. https://doi.org/10.1186/s13098-025-01765-x
MLA
Liu, Renjiao, et al. "Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment.." Diabetology & metabolic syndrome, 2025. https://doi.org/10.1186/s13098-025-01765-x
RethinkPeptides
RethinkPeptides Research Database. "Weight loss mediates improvement in proinsulin processing du..." RPEP-12234. Retrieved from https://rethinkpeptides.com/research/liu-2025-weight-loss-mediates-improvement
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.